Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results

Core Points - Zealand Pharma A/S will host a conference call on November 13, 2025, at 2:00 pm CET (8:00 am ET) to present its third quarter 2025 financial results [1] - The call will feature key executives including President and CEO Adam Steensberg, CFO Henriette Wennicke, and CMO David Kendall, followed by a Q&A session [2] - Participants can register for the call and access the live audio webcast through provided links, with a recording available post-event on the company's website [3] Company Overview - Zealand Pharma A/S is a biotechnology company focused on the discovery and development of innovative peptide-based medicines, with over 10 drug candidates in clinical development, including two on the market and three in late-stage development [4] - The company has established development and commercial partnerships with various pharmaceutical companies for its marketed products [4] - Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma also has a presence in the U.S. [5]